314 related articles for article (PubMed ID: 9663809)
21. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ; Playford DA; Watts GF
Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina.
Moriyama Y; Tsunoda R; Harada M; Miyao Y; Yoshimura M; Kugiyama K; Ogawa H; Yasue H
Jpn Circ J; 2001 Feb; 65(2):81-6. PubMed ID: 11216830
[TBL] [Abstract][Full Text] [Related]
23. Relative contribution of vasodilator prostanoids, NO, and KATP channels to human forearm metabolic vasodilation.
Farouque HM; Meredith IT
Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2405-11. PubMed ID: 12598235
[TBL] [Abstract][Full Text] [Related]
24. Contribution of nitric oxide to beta2-adrenoceptor mediated vasodilatation in human forearm arterial vasculature.
Majmudar NG; Anumba D; Robson SC; Ford GA
Br J Clin Pharmacol; 1999 Feb; 47(2):173-7. PubMed ID: 10190652
[TBL] [Abstract][Full Text] [Related]
25. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
26. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
27. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase.
Heitzer T; Brockhoff C; Mayer B; Warnholtz A; Mollnau H; Henne S; Meinertz T; Münzel T
Circ Res; 2000 Feb; 86(2):E36-41. PubMed ID: 10666424
[TBL] [Abstract][Full Text] [Related]
28. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle.
Schrage WG; Dietz NM; Eisenach JH; Joyner MJ
J Appl Physiol (1985); 2005 Apr; 98(4):1251-7. PubMed ID: 15563630
[TBL] [Abstract][Full Text] [Related]
29. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men.
Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP
Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494
[TBL] [Abstract][Full Text] [Related]
30. Vasoconstrictor products of cyclo-oxygenase activity limit acetylcholine-induced cutaneous vasodilatation in young men.
Hendry RG; Marshall JM
Clin Sci (Lond); 2004 Sep; 107(3):323-30. PubMed ID: 15202930
[TBL] [Abstract][Full Text] [Related]
31. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor.
Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA
J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
33. Methodological validity and feasibility of the nitric oxide clamp technique for nitric oxide research in human resistant vessels.
Ueda S; Wada A; Umemura S
Hypertens Res; 2004 May; 27(5):351-7. PubMed ID: 15198483
[TBL] [Abstract][Full Text] [Related]
34. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: indirect evidence for the role of endothelium-derived hyperpolarizing factor.
Katz SD; Krum H
Am J Cardiol; 2001 May; 87(9):1089-92. PubMed ID: 11348607
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans.
Durand S; Tartas M; Bouyé P; Koïtka A; Saumet JL; Abraham P
J Physiol; 2004 Dec; 561(Pt 3):811-9. PubMed ID: 15498811
[TBL] [Abstract][Full Text] [Related]
36. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
Dawes M; Chowienczyk PJ; Ritter JM
Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
[TBL] [Abstract][Full Text] [Related]
37. Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.
Dietz NM; Engelke KA; Samuel TT; Fix RT; Joyner MJ
J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):531-40. PubMed ID: 9032700
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide-mediated vasodilation in human pregnancy.
Williams DJ; Vallance PJ; Neild GH; Spencer JA; Imms FJ
Am J Physiol; 1997 Feb; 272(2 Pt 2):H748-52. PubMed ID: 9124434
[TBL] [Abstract][Full Text] [Related]
39. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin.
Noon JP; Walker BR; Hand MF; Webb DJ
Cardiovasc Res; 1998 May; 38(2):480-4. PubMed ID: 9709409
[TBL] [Abstract][Full Text] [Related]
40. The contribution of nitric oxide to exercise hyperemia in the human forearm.
Gordon MB; Jain R; Beckman JA; Creager MA
Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
